Table 1.
All participants | Intervention group | Control group | |||||
N (=15) | % | N (=8) | % | N (=7) | % | ||
Age | Median (range) | 58 (21–77) | 52 (21–64) | 65 (48–77) | |||
Education* | Low | 1 | 6.7 | 0 | 0.0 | 1 | 14.3 |
Medium | 8 | 53.3 | 5 | 62.5 | 3 | 42.9 | |
High | 6 | 40.0 | 3 | 37.5 | 3 | 42.9 | |
Smoking status | Never smoker | 8 | 53.3 | 4 | 50.0 | 4 | 57.1 |
Former smoker | 5 | 33.3 | 3 | 37.5 | 2 | 28.6 | |
Current smoker | 2 | 13.3 | 1 | 12.5 | 1 | 14.3 | |
Alcohol use per week | <1 g | 5 | 33.3 | 3 | 37.5 | 2 | 28.6 |
1–12 g | 1 | 6.7 | 0 | 0.0 | 1 | 14.3 | |
13–24 g | 3 | 20.0 | 3 | 37.5 | 0 | 0.0 | |
25–48 g | 4 | 26.7 | 1 | 12.5 | 3 | 42.9 | |
49–60 g | 2 | 13.3 | 1 | 12.5 | 1 | 14.3 | |
Body mass index | Underweight (<18.5) | 1 | 6.7 | 1 | 12.5 | 0 | 0.0 |
Normal weight (18.5–24.9) | 9 | 60.0 | 4 | 50.0 | 5 | 71.4 | |
Overweight (25.0–29.9) | 2 | 13.3 | 1 | 12.5 | 1 | 14.3 | |
Obesity (≥30.0) | 3 | 20.0 | 2 | 25.0 | 1 | 14.3 | |
Sports† | 0–4 MET h/week | 9 | 60.0 | 6 | 75.0 | 3 | 42.9 |
5–10 MET h/week | 1 | 6.7 | 1 | 12.5 | 0 | 0.0 | |
>10 MET h/week | 5 | 33.3 | 1 | 12.5 | 4 | 57.1 | |
Cancer stage‡ | I | 2 | 13.3 | 1 | 12.5 | 1 | 14.3 |
II | 2 | 13.3 | 0 | 0.0 | 2 | 28.6 | |
III | 9 | 60.0 | 6 | 75.0 | 3 | 42.9 | |
IV | 2 | 13.3 | 1 | 12.5 | 1 | 14.3 | |
Tumour size postop | Tumor-free | 8 | 53.3 | 4 | 50.0 | 4 | 57.1 |
<1 cm | 5 | 33.3 | 2 | 25.0 | 3 | 42.9 | |
>1 cm | 2 | 13.3 | 2 | 25.0 | 0 | 0.0 | |
Treatment | Adjuvant chemotherapy | 12 | 80.0 | 6 | 75.0 | 6 | 85.7 |
Neo-adjuvant chemotherapy | 3 | 20.0 | 2 | 25.0 | 1 | 14.3 |
*CASMIN classification35
†SQUASH questionnaire20
‡FIGO classification36
CASMIN, Comparative Analysis of Social Mobility in Industrial Nations; FIGO, International Federation of Gynecology and Obstetrics; MET, metabolic equivalent of task; SQUASH, Short Questionnaire to Assess Health enhancing physical activity.